Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Rinri Therapeutics, a biotechnology company developing a novel stem cell therapy to restore hearing, today […]
U.S. FDA Approves NEXTSTELLIS ®, New Oral Contraceptive
Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS […]
RETINA-AI Health Awarded U.S. Patent for AI Eye Disease Detection
RETINA-AI Health Inc. has been awarded a U.S. patent on its Artificial Intelligence (AI) systems […]
Altair Medical Secures $3.1m in Pre-Series A financing
UK based Altair Medical today announced it has secured £2.25m ($3.1m) of Pre-Series A funding […]
Microsoft Accelerates Industry Cloud Strategy for Healthcare with the Acquisition of Nuance
Microsoft Corp and Nuance Communications, Inc. today announced they have entered into a definitive agreement […]
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
Medable Inc. today announced $78 million in new funding to fuel advances in the delivery […]
Oregon Oncology Specialists Integrate AI-screening Solution VIPER™ Into Network
Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep […]
Festival Republic Joins Government Pilot Programme with a Live Event to Trial the Safe Return of Fans
The Sefton Park Pilot, in partnership with Culture Liverpool, will further trial approaches to managing […]
Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases
Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]
Novavax to Participate in Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more